- Home
- ABEO vs SMTI Comparison
ABEO vs SMTI Comparison
Compare ABEO & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- SMTI
- Stock Information
- Founded
- ABEO N/A
- SMTI 1982
- Country
- ABEO United States
- SMTI United States
- Employees
- ABEO N/A
- SMTI N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- ABEO Health Care
- SMTI Health Care
- Exchange
- ABEO Nasdaq
- SMTI Nasdaq
- Market Cap
- ABEO 247.8M
- SMTI 288.2M
- IPO Year
- ABEO 1980
- SMTI N/A
- Fundamental
- Price
- ABEO $5.70
- SMTI $33.01
- Analyst Decision
- ABEO Strong Buy
- SMTI Buy
- Analyst Count
- ABEO 3
- SMTI 1
- Target Price
- ABEO $18.00
- SMTI $44.00
- AVG Volume (30 Days)
- ABEO 229.2K
- SMTI 36.4K
- Earning Date
- ABEO 11-14-2024
- SMTI 11-12-2024
- Dividend Yield
- ABEO N/A
- SMTI N/A
- EPS Growth
- ABEO N/A
- SMTI N/A
- EPS
- ABEO N/A
- SMTI N/A
- Revenue
- ABEO N/A
- SMTI $78,056,873.00
- Revenue This Year
- ABEO N/A
- SMTI $29.95
- Revenue Next Year
- ABEO $18,714.71
- SMTI $19.68
- P/E Ratio
- ABEO N/A
- SMTI N/A
- Revenue Growth
- ABEO 147.52
- SMTI 24.66
- 52 Week Low
- ABEO $3.05
- SMTI $26.00
- 52 Week High
- ABEO $9.01
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- ABEO 34.30
- SMTI 34.95
- Support Level
- ABEO $5.45
- SMTI $31.13
- Resistance Level
- ABEO $6.04
- SMTI $34.22
- Average True Range (ATR)
- ABEO 0.19
- SMTI 1.80
- MACD
- ABEO -0.04
- SMTI -0.63
- Stochastic Oscillator
- ABEO 19.47
- SMTI 12.98
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.